Elevated cholesterol levels have a poor prognosis in a cholestasis scenario

J Biochem Mol Toxicol. 2017 Jan;31(1):1-6. doi: 10.1002/jbt.21831. Epub 2016 Aug 12.

Abstract

Cholestasis results from defective bile flow through the biliary ducts leading to the accumulation of bile acids (BAs) in hepatocytes and serum. It has been seen that cholestasis is associated with hypercholesterolemia, which is a prerequisite for gallstone formation and primary biliary cirrhosis, being some of the most common gastrointestinal disorders in Western societies. Cytotoxic BAs induce proinflammatory mediators, oxidative stress, and apoptosis in hepatocytes, whereas cytoprotective BAs prevent them; they can also modify the plasmatic membrane structure of cells or mitochondrial outer membrane properties as well as the distribution of cholesterol, altering various proteins involved in BAs homeostasis.

Keywords: bile acids; cholestasis; cholesterol.

Publication types

  • Review

MeSH terms

  • Apoptosis
  • Bile Acids and Salts / blood
  • Cell Membrane / metabolism
  • Cell Membrane / pathology
  • Cholestasis / blood*
  • Cholestasis / diagnosis
  • Cholestasis / etiology
  • Cholestasis / pathology
  • Cholesterol / blood*
  • Hepatocytes / metabolism
  • Hepatocytes / pathology
  • Humans
  • Hypercholesterolemia / blood*
  • Hypercholesterolemia / complications
  • Hypercholesterolemia / diagnosis
  • Hypercholesterolemia / pathology
  • Inflammation Mediators / blood
  • Mitochondria, Liver / metabolism
  • Mitochondria, Liver / pathology
  • Mitochondrial Membranes / metabolism
  • Mitochondrial Membranes / pathology
  • Oxidative Stress
  • Prognosis

Substances

  • Bile Acids and Salts
  • Inflammation Mediators
  • Cholesterol